NVO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Novo Nordisk A/S's quarterly common stock declined from Sep. 2015 ($78 Mil) to Dec. 2015 ($76 Mil) but then increased from Dec. 2015 ($76 Mil) to Mar. 2016 ($78 Mil).
Novo Nordisk A/S's annual common stock declined from Dec. 2013 ($101 Mil) to Dec. 2014 ($88 Mil) and declined from Dec. 2014 ($88 Mil) to Dec. 2015 ($76 Mil).
Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.
The par value of common stocks is meaningless. It is usually set at an absurdly low number.
Novo Nordisk A/S Annual Data
Novo Nordisk A/S Quarterly Data